Menu
Home
Advanced Search
Directory of Libraries
About lib.ir
Contact Us
History
ورود / ثبت نام
عنوان
Clinical laboratories in China :
پدید آورنده
edited by Philip M. Parker.
موضوع
Pathological laboratories-- China.,Pathological laboratories-- Economic aspects-- China.,MEDICAL-- Pathology.,MEDICAL-- Pathophysiology.,Pathological laboratories-- Economic aspects.,Pathological laboratories.,China., 7
رده
RB36
.
C55
2007eb
کتابخانه
Center and Library of Islamic Studies in European Languages
محل استقرار
استان:
Qom
ـ شهر:
Qom
تماس با کتابخانه :
32910706
-
025
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
1429499494
(Number (ISBN
9781429499491
NATIONAL BIBLIOGRAPHY NUMBER
Number
b728089
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Clinical laboratories in China :
General Material Designation
[Book]
Other Title Information
a strategic reference, 2006 /
First Statement of Responsibility
edited by Philip M. Parker.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
[San Diego, Calif.] :
Name of Publisher, Distributor, etc.
Icon Group International,
Date of Publication, Distribution, etc.
©2007.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource.
GENERAL NOTES
Text of Note
Title from PDF cover (viewed Sep. 27, 2007).
CONTENTS NOTE
Text of Note
Cover -- Contents -- 1 INTRODUCTION & METHODOLOGY -- 1.1 WHAT DOES THIS REPORT COVER? -- 1.2 HOW TO STRATEGICALLY EVALUATE CHINA -- 1.3 LATENT DEMAND AND ACCESSIBILITY IN CHINA -- 2 CLINICAL LABORATORIES IN CHINA -- 2.1 LATENT DEMAND AND ACCESSIBILITY: BACKGROUND -- 2.2 LATENT DEMAND: MARKET COMPOSITION -- 2.2.1 Healthcare -- 2.2.2 Testing Facilities -- 2.3 LATENT DEMAND: STATISTICAL DATA -- 2.3.1 Import Statistics and Trends -- 2.4 LATENT DEMAND: LEADING SEGMENTS -- 2.5 KEY SUPPLIERS -- 2.6 ACCESSIBILITY: MARKET ENTRY -- 2.7 MARKET ISSUES AND OBSTACLES -- 2.7.1 Duties -- 2.7.2 Distribution Issues -- 2.7.3 Standardization -- 2.7.4 Staff -- 3 FINANCIAL INDICATORS: LABORATORY ANALYTICAL INSTRUMENTS -- 3.1 OVERVIEW -- 3.1.1 Financial Returns and Gaps in China -- 3.1.2 Labor Productivity Gaps in China -- 3.1.3 Limitations and Extensions -- 3.2 FINANCIAL RETURNS IN CHINA: ASSET STRUCTURE RATIOS -- 3.2.1 Overview -- 3.2.2 Assets -- Definitions of Terms -- 3.2.3 Asset Structure: Outlook -- 3.2.4 Large Variances: Assets -- 3.2.5 Key Percentiles and Rankings -- 3.3 FINANCIAL RETURNS IN CHINA: LIABILITY STRUCTURE RATIOS -- 3.3.1 Overview -- 3.3.2 Liabilities and Equity -- Definitions of Terms -- 3.3.3 Liability Structure: Outlook -- 3.3.4 Large Variances: Liabilities -- 3.3.5 Key Percentiles and Rankings -- 3.4 FINANCIAL RETURNS IN CHINA: INCOME STRUCTURE RATIOS -- 3.4.1 Overview -- 3.4.2 Income Statements -- Definitions of Terms -- 3.4.3 Income Structure: Outlook -- 3.4.4 Large Variances: Income -- 3.4.5 Key Percentiles and Rankings -- 3.5 FINANCIAL RETURNS IN CHINA: PROFITABILITY RATIOS -- 3.5.1 Overview -- 3.5.2 Ratios -- Definitions of Terms -- 3.5.3 Ratio Structure: Outlook -- 3.5.4 Large Variances: Ratios -- 3.5.5 Key Percentiles and Rankings -- 3.6 PRODUCTIVITY IN CHINA: ASSET-LABOR RATIOS -- 3.6.1 Overview -- 3.6.2 Asset to Labor: Outlook -- 3.6.3 Asset to Labor: International Gaps -- 3.6.4 Key Percentiles and Rankings -- 3.7 PRODUCTIVITY IN CHINA: LIABILITY-LABOR RATIOS -- 3.7.1 Overview -- 3.7.2 Liability to Labor: Outlook -- 3.7.3 Liability and Equity to Labor: International Gaps -- 3.7.4 Key Percentiles and Rankings -- 3.8 PRODUCTIVITY IN CHINA: INCOME-LABOR RATIOS -- 3.8.1 Overview -- 3.8.2 Income to Labor: Outlook -- 3.8.3 Income to Labor: Gaps -- 3.8.4 Key Percentiles and Rankings -- 4 MACRO-ACCESSIBILITY IN CHINA -- 4.1 EXECUTIVE SUMMARY -- 4.1.1 Government Intervention Risks -- 4.1.2 Infrastructure Investment -- 4.2 POLITICAL RISKS -- 4.3 MARKETING STRATEGIES -- 4.3.1 Distribution Channel Options -- 4.3.2 Establishing a Presence in China -- 4.3.3 Selling Strategies -- 4.3.4 Advertising and Trade Promotion -- 4.3.5 Pricing Issues -- 4.3.6 Selling to the Government -- 4.3.7 Intellectual Property Risks -- 4.3.8 Local Professional Services -- 4.3.9 Performing Due Diligence -- 4.4 IMPORT AND EXPORT REGULATION RISKS -- 4.4.1 Import Tariffs and Customs Regulations -- 4.4.2 Trade Barrier Risks -- 4.4.3 Import Documentation Requirements -- 4.4.4 Controls on Exports -- 4.4.5 Export Controls -- 4.4.6 Inspection Standards -- 4.4.7 Labeling Issues -- 4.4.8 Additional Trade Issues -- 4.4.9 Restrictions on Imports -- 4.4.10 Customs Contact Information -- 4.5 INVESTMENT CLIMATE --T$1670.
0
SUMMARY OR ABSTRACT
Text of Note
This report provides a detailed overview of factors driving latent demand and accessibility for clinical laboratories in China.
TOPICAL NAME USED AS SUBJECT
Pathological laboratories-- China.
Pathological laboratories-- Economic aspects-- China.
MEDICAL-- Pathology.
MEDICAL-- Pathophysiology.
Pathological laboratories-- Economic aspects.
Pathological laboratories.
GEOGRAPHICAL NAME USED AS SUBJECT
China.
7
(SUBJECT CATEGORY (Provisional
K
MED-- 067000
MED-- 068000
DEWEY DECIMAL CLASSIFICATION
Number
616
.
07
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RB36
Book number
.
C55
2007eb
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Parker, Philip M.,1960-
ORIGINATING SOURCE
Date of Transaction
20201214050340.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب
[Book]
Y
Proposal/Bug Report
×
Proposal/Bug Report
×
Warning!
Enter The Information Carefully
Error Report
Proposal